The impact of percutaneous peripheral interventions on endothelial function.

Background: Treatment of symptomatic peripheral artery disease (PAD) through endovascular interventions is the primary revascularization strategy. Interventions restore perfusion but may cause severe injury to the vascular endothelium, which regulates vascular tone. Endothelial dysfunction is involved in the progression of cardiovascular disease, with higher incidences of vascular events. We aimed to determine the impact of percutaneous interventions on change in endothelial function. Patients and methods: Endothelial function was determined using flow-mediated dilation (FMD) before, the day after lower limb intervention with paclitaxel-coated balloons or stent guided interventions and after a six-month follow-up in the target limb, control limb and the systemic circulation in 42 PAD patients aged 70.2±9 years and 66% men. Additionally, macro- and microvascular function were assessed. Results: In PAD patients aged 70.2±9 years and 66% men, we observed an immediate enhancement of macro-, microvascular and endothelial function after endovascular treatment (FMD of superficial femoral artery (SFA) 3.7±0.2% to 4.1±0.1%, n=42, p=0.02), a sustained long-term improvement after 6-months (FMD SFA 3.7±0.2% to 4.2±0.1%, n=42, p=0.01), and moreover an improved systemic endothelial function (FMD brachial artery 4.3±0.1% to 4.7±0.2, n=42, p=0.01) following peripheral interventions. Subgroup analysis however revealed that following paclitaxel-based percutaneous intervention, the paclitaxel dosage applied was inversely related to the chronic improvement in local endothelial function (r=-0.6, n=22, p=0.005) without evidence for systemic effects (r=-0.25, p=0.27). Conclusions: We demonstrate an improved local and systemic endothelial function after treatment of atherosclerotic peripheral disease with a distinguished response after endovascular intervention with higher dosage of applied paclitaxel restraining the benefits. Further studies have to determine the optimal interventional strategy with respect to different treatment modalities to maintain vessel functions.

[1]  M. Jaff,et al.  Paclitaxel and Mortality: The Dose Argument Is Critical , 2019, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[2]  T. Rassaf,et al.  Rapid and automated risk stratification by determination of the aortic stiffness in healthy subjects and subjects with cardiovascular disease , 2019, PloS one.

[3]  F. Vogt,et al.  The effects of stenting on coronary endothelium from a molecular biological view: Time for improvement? , 2018, Journal of cellular and molecular medicine.

[4]  M. Totzeck,et al.  Percutaneous Mitral Valve Repair in Mitral Regurgitation Reduces Cell-Free Hemoglobin and Improves Endothelial Function , 2016, PloS one.

[5]  F. Vermassen,et al.  Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. , 2014, Journal of the American College of Cardiology.

[6]  T. Rassaf,et al.  Dietary nitrate reverses vascular dysfunction in older adults with moderately increased cardiovascular risk. , 2014, Journal of the American College of Cardiology.

[7]  T. Rassaf,et al.  Macrophage migration inhibitory factor is associated with vascular dysfunction in patients with end-stage renal disease. , 2013, International journal of cardiology.

[8]  R. Draijer,et al.  Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. , 2013, International journal of cardiology.

[9]  Kim Van der Heiden,et al.  The effects of stenting on shear stress: relevance to endothelial injury and repair. , 2013, Cardiovascular research.

[10]  E. Kim,et al.  Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent. , 2008, JACC. Cardiovascular interventions.

[11]  D. Green,et al.  Flow‐mediated dilatation in the superficial femoral artery is nitric oxide mediated in humans , 2008, The Journal of physiology.

[12]  T. Meinertz,et al.  Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.

[13]  George L. Adams,et al.  Technique Optimization of Orbital Atherectomy in Calcified Peripheral Lesions of the Lower Extremities: The CONFIRM Series, A Prospective Multicenter Registry , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.